Peking University People's Hospital: clinical-trial pipeline
Peking University People's Hospital is the sponsor of 603 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 205 are not yet finished and 20 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials205
Phase 2/3 and 330
Countries1
New in 90 days20
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 396 |
| Phase 2 | 105 |
| Phase 4 | 27 |
| Phase 1/2 | 24 |
| Phase 3 | 22 |
| Phase 1 | 13 |
| Early phase 1 | 8 |
| Phase 2/3 | 8 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 281 |
| Recruiting | 115 |
| Completed | 102 |
| Not yet recruiting | 76 |
| Active, not recruiting | 14 |
| Withdrawn or not authorised | 8 |
| Terminated | 4 |
| Suspended or halted | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 240 |
| Immunology and rheumatology | 123 |
| Cardiovascular | 69 |
| Haematology | 68 |
| Musculoskeletal | 63 |
| Women's health and obstetrics | 39 |
| Rare and genetic diseases | 31 |
| Infectious disease and vaccines | 25 |
| Gastroenterology and liver | 22 |
| Respiratory | 21 |
| Ophthalmology | 19 |
| Dermatology | 16 |
Countries
| Country | Trials |
|---|---|
| China | 472 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLC |
| 2026-10-16 | New trial posted | Prospective ctDNA Testing in Large B-Cell Lymphoma |
| 2026-10-16 | New trial posted | Effect of Weight Management on AMPK Activation in the Adjunctive Treatment of Endometrial… |
| 2026-10-14 | New trial posted | MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLC |
| 2026-10-09 | New trial posted | NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Contro… |
| 2026-10-05 | New trial posted | LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial) |
| 2026-10-02 | New trial posted | VAAPS Combined With Loose Seton Drainage for Postoperative Self-Care: A Prospective Singl… |
| 2026-09-30 | New trial posted | Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in… |
| 2026-09-28 | New trial posted | A Prospective, Open-label, Randomized Trial Comparing Switch to A1811 Versus Continued TH… |
| 2026-09-28 | New trial posted | ADC Based Therapy Accroding to HER2 Heterogeneous |
| 2026-09-28 | New trial posted | Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease |
| 2026-09-22 | New trial posted | Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym. |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06778603 | B7-H3 NIR Imaging for Osteosarcoma Surgery | Phase 1/2 | Recruiting | China |
| NCT07187882 | Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo | Not applicable | Recruiting | China |
| NCT07441291 | CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT | Phase 3 | Recruiting | China |
| NCT07550452 | Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With… | Not applicable | Not yet recruiting | |
| NCT07833163 | Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym. | Phase 2 | Not yet recruiting | China |
| NCT07653711 | Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease | Not applicable | Recruiting | China |
| NCT06627309 | Rapid dFLC Response Predict CHR in AL Amyloidosis | Not applicable | Recruiting | China |
| NCT07432048 | Non-Invasive Dynamic Monitoring-Guided Oscillation and Lung Expansion for Airway Clearance in Severe Blunt Ch… | Not applicable | Not yet recruiting | |
| NCT07318727 | Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patient… | Not applicable | Recruiting | China |
| NCT07569055 | Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation | Not applicable | Recruiting | China |
| NCT07656766 | Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer | Phase 2 | Not yet recruiting | China |
| NCT07119190 | A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immuno… | Not applicable | Not yet recruiting | |
| NCT07511595 | Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients | Not applicable | Not yet recruiting | |
| NCT07349498 | Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation | Not applicable | Recruiting | China |
| NCT06475430 | Fecal Microbiota Transplantation in the Treatment of Major LARS | Not applicable | Not yet recruiting | |
| NCT07574346 | IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies | Early phase 1 | Recruiting | China |
| NCT06557304 | The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China | Not applicable | Not yet recruiting | |
| NCT06655519 | An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell… | Phase 1 | Not yet recruiting | |
| NCT07294339 | A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Recep… | Not applicable | Not yet recruiting | China |
| NCT07487883 | Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors | Not applicable | Recruiting | China |
| NCT07516002 | Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency | Not applicable | Not yet recruiting | |
| NCT07075250 | Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Plati… | Phase 4 | Not yet recruiting | |
| NCT06302465 | Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions a… | Not applicable | Recruiting | China |
| NCT07407660 | Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients… | Phase 3 | Not yet recruiting | |
| NCT07737262 | Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anem… | Phase 3 | Not yet recruiting |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Peking University People's Hospital clinical trials: 205 open, 30 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/peking-university-people-s-hospital/, data as of 2026-10-25.